Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
Eric Mosbrooker currently holds 79,010 shares of Audentes Therapeutics, Inc. (BOLD), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Eric Mosbrooker has been a net seller of BOLD stock. They have purchased $0 and sold $6.4M worth of shares.
Eric Mosbrooker's most recent insider trade was on Dec 17, 2025, when they sold 11,426 shares at $71.87 per share.
Eric Mosbrooker serves as Executive at Audentes Therapeutics, Inc. (BOLD). They have executed 15 insider transactions totaling $6.4M over their tenure at the company.
Eric Mosbrooker holds the position of Executive at Audentes Therapeutics, Inc., where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 9 years and currently hold a stake valued at $0.
Eric Mosbrooker has shown a selling trading pattern, with $0 in total purchases and $6.4M in total sales across all transactions. Their most recent activity indicates a tendency to reduce their position.
The largest transaction by Eric Mosbrooker was on Aug 6, 2025, when they sold $5.5M worth of RNA shares. This transaction involved 124,687 shares at $44.06 per share.
Eric Mosbrooker currently owns 79,010 shares of Audentes Therapeutics, Inc. (BOLD), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of Eric Mosbrooker's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. Eric Mosbrooker has 15 Form 4 filings on record as an insider at Audentes Therapeutics, Inc..
Set alerts for Eric Mosbrooker and 40,000+ other insiders.